ArticleJournal of military, veteran and family health2023
Investigating factors associated with medicinal cannabis authorization dosage among military Veterans in Canada.
Article in Journal of military, veteran and family health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Since 2008, Veterans Affairs Canada (VAC) has provided Canadian Armed Forces Regular Force Veterans with reimbursement of Cannabis for Medical Purposes (CMP) authorizations. The authorized dosage and authorization criteria have changed with time. This study investigated factors associated with CMP authorizations and dosage among CMP-authorized Veterans. Methods: CMP authorizations among 9,104 Veterans residing in Canada on Dec. 31, 2020, were linked with VAC reimbursement, VAC client, and military personnel records. Multivariable logistic regression models were used to examine relationships between CMP dosage and socio-demographic, health, and military characteristics. Results: Among Veterans with CMP authorizations, the strongest associations with a larger authorization dosage (4-10 grams vs. 1-3 grams) were observed for Veterans receiving benefits for mental health conditions in combination with other health conditions (OR = 3.47 compared with those with no mental health conditions). A larger authorization dosage was associated with province of residence (OR = 3.36 for New Brunswick compared with Ontario), earlier year of authorization (OR = 2.19 for 2014) compared with 2016, being male (OR = 1.68), active participation in a rehabilitation program (OR = 1.45), land environment at the time of release from military service (OR = 1.24) compared with air environments, and involuntary release from service (OR = 1.65) and medical release (OR = 1.11) compared with voluntary release. Discussion: Factors associated with larger CMP authorization dosage among military Veterans in Canada appeared multifactorial, spanning socio-demographic, health, and military characteristics. This complexity should be considered by treatment providers and clinicians working with military Veterans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.